The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis post-liver transplant: a case series.
Hunter RaganElizabeth J BeckmanTaryn BomersbackJennifer HewlettLauren KormelinkJulie SafirsteinLaura ShanleyLisa LubschPublished in: Pediatric pulmonology (2021)
Initiation of elx/tez/iva in patients with CF who received a liver transplantation may be safe with clinical benefits. This article is protected by copyright. All rights reserved.